Chief Editor: Nonia Pariente Nonia received a PhD in molecular biology from the Autonoma University of Madrid studying RNA virus evolution and new antiviral strategies with Esteban Domingo. She then moved to UCLA, where she focused on developing lentiviral vectors for gene therapy in Irvin Chen’s laboratory. In 2007, Nonia joined the EMBO reports editorial team, were she spent a total of eight years, becoming Senior Editor in 2012. There she was responsible for microbiology and immunology, among other areas, and spent many years broadening her understanding and love for all things microbial. In September 2015, Nonia joined the launch team of Nature Microbiology, where she has worked ever since, except for two locum periods as microbiology editor at Nature. She became Chief Editor in March 2019. nonia.pariente@nature.com orcid.org/0000-0002-3666-5683 Senior Editor: Cláudio Nunes-AlvesCláudio studied biochemistry at the University of Porto, Portugal, before earning his Ph.D. in Life and Health Sciences. He shared his time between Portugal and the United States, in the laboratories of Margarida Correia-Neves (at the Life and Health Sciences Research Institute, Braga, Portugal), Sam Behar (then at the Brigham and Women's Hospital, Boston, Massachusetts, USA) and Christophe Benoist (at Harvard Medical School, Boston, Massachusetts, USA), studying multiple aspects of immunity to tuberculosis. These included clarifying the role of CD8+ T cells following Mycobacterium tuberculosis challenge and how infection of the thymus affects ongoing immunity to tuberculosis. After a brief postdoctoral position with Sam Behar at the University of Massachusetts Medical School, USA, Cláudio joined the Nature Reviews Microbiology team as an Associate Editor in April 2014 and after a successful period as locum Chief Editor in 2015, he became a Senior Editor. Cláudio joined the Nature Microbiology team in March 2016. claudio.nunes-alves@nature.com orcid.org/0000-0001-9639-0477 Senior Editor: Emily WhiteEmily received a B.Sc. in Microbiology and further developed her knowledge by studying for a PhD in Microbiology at the University of Manchester. Her time was split between the laboratories of Ian Roberts and Richard Grencis, looking at the interactions between the mammalian intestinal microbiota and the intestinal helminth parasite Trichuris muris. Emily joined the Nature Microbiology team in November 2016. emily.white@nature.com orcid.org/0000-0002-2314-5718 Associate Editor: Paula JáureguiPaula studied Biology and Biochemistry at the University of Navarre, Spain. She earned her PhD studying lentiviral restriction factors, focusing on Visna-Maedi Virus in the laboratory of Beatriz Amorena, supervised by Ramses Reina and Damian de Andres at the Public University of Navarre, Spain. She then moved to New York to undertake postdoctoral studies in Nathaniel Landau’s lab at NYU. There, her research was focused on HIV-1-host interactions and the role of HIV-1 accessory proteins in pathogenesis. She then moved to Innsbruck, Austria, where she worked in Doris Wilflingseder’s lab as a senior postdoc, studying complement opsonisation of HIV and its implications in pathogenesis, host response and viral infection. Paula joined the Nature Microbiology team in October 2019. paula.jauregui@nature.com orcid.org/0000-0001-9677-3822 Associate Editor: François MayerFrançois studied Microbiology at the Technical University Braunschweig in Germany, and investigated biofilms of the pathogenic bacterium Pseudomonas aeruginosa during his Diploma thesis in the laboratory of Dieter Jahn. He then earned his PhD in Microbiology studying novel infection-associated genes in the human fungal pathogen Candida albicans in the laboratory of Bernhard Hube at the Hans-Knoell-Institute in Jena, Germany. Following a short postdoc in Bernhard Hube’s lab, he then moved to Vancouver, Canada, to perform postdoctoral studies in the laboratory of Jim Kronstad at the Michael Smith Laboratories, University of British Columbia. There, his research focus was on virulence factor production by the human fungal pathogen Cryptococcus neoformans, antifungal drug discovery, and fungal-bacterial interactions. François joined the Nature Microbiology team in September 2019. francois.mayer@nature.com orcid.org/0000-0002-6800-9429
|